PHYSICIAN CONTINUING MEDICAL EDUCATION*

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Postgraduate Institute for Medicine and Center of Excellence Media, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

The Postgraduate Institute for Medicine designates this live activity for a maximum of 18..5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

DISCLOSURE OF CONFLICTS OF INTEREST 

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted and resolved according to PIM policy. The existence or absence of COIs for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

AMERICANs WITH DISABILITIES ACT 

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Linda Mezzacappa prior to the live event at (732) 992-1520.

This educational initiative is directed toward medical and surgical oncologists, dermatologists, and radiation oncologists involved in the

treatment of patients with cutaneous malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and

other healthcare professionals interested in the treatment of cutaneous malignancies are also invited to participate.

This meeting is also directed toward medical oncologists and hematologists, pathologists, geneticists, advanced practice oncology/

hematology nurses, research nurses, clinical oncology pharmacists, and genetic counselors involved in the management of patients

with solid cancers or hematologic malignancies, and interested in the use of molecular biomarkers to help optimize patient care. Research

scientists interested in the fi eld of molecular biomarkers in oncology are also invited to participate.